You are here: Home > Institute of Excellence (CPD) > CPD Events > ACO Dry Eye Short Course (DESC 2026)

ACO Dry Eye Short Course (DESC 2026)

Date: 10/08/2026 - 26/10/2026

Venue: Online, 3000, AUSTRALIA

Provider: Australian College of Optometry

Contact: Shazia Tahseen, [E] cpd@aco.org.au, [P] 03 9349 7546

Activity Outline

The ACO Dry Eye Short Course is designed to enhance clinical expertise in the diagnosis and management of dry eye disease. Guided by leading experts, including TFOS DEWS III Vice Chair Professor James S. Wolffsohn, participants will develop practical skills in tear filM assessment, evidence-based treatment, personalised management, and pharmacological care. Through five online modules and interactive case discussion webinars, clinicians will gain the knowledge and confidence to optimise outcomes and grow their dry eye practice.

Learning Objectives

  • Explain the anatomical and physiological components of the ocular surface, eyelids, and tear film, and their role in maintaining ocular surface health
  • Define dry eye disease and describe its classification, prevalence, and incidence to understand its global impact
  • Evaluate the underlying pathophysiological mechanisms of dry eye disease, including inflammation, tear film instability, and meibomian gland dysfunction, to inform clinical understanding and treatment planning
  • Apply structured clinical history-taking methods to gather comprehensive information relevant to dry eye assessment
  • Utilise standardized symptom questionnaires to accurately evaluate and quantify patient-reported dry eye symptoms
  • Perform and interpret ocular surface examination techniques to identify clinical signs associated with dry eye disease
  • Develop strategies to effectively educate patients about Dry Eye Disease, including its management, treatment options, and prognosis, to improve understanding and engagement in care.
  • Compare the indications, benefits, and limitations of first-line non-pharmacological therapies for Dry Eye Disease
  • Design evidence based individualized first line treatment plans
  • Describe the role of nutrition in dry eye disease (DED) pathophysiology
  • Summarise the evidence for key nutritional interventions in DED
  • Apply nutrition-based strategies as adjuncts to conventional DED management
  • Counsel patients on realistic, evidence-informed dietary approaches
  • Evaluate the mechanistic pathways targeted by anti-inflammatory pharmacological therapies
  • Appraise the clinical evidence supporting the indications, efficacy, safety, and limitations of key anti-inflammatory DED therapies such as corticosteroids, calcineurin inhibitors, and LFA-1 antagonists
  • Design evidence-based treatment strategies that incorporate topical corticosteroids and immunomodulators such as cyclosporin for appropriate clinical scenarios.
  • Reframe antibiotics in dry eye disease from simple anti-infective agents to mechanism-based biomodulatory therapies
  • Highlight the role of inflammation and lid-margin dysfunction in dry eye disease
  • Understand the relationship between dry eye disease and mental health, to ensure empathetic consultation and communication
  • Understand the quality of life impacts dry eye has on patients.
  • Analyse the mechanisms and risk factors contributing to post-surgical Dry Eye Disease (e.g., LASIK, cataract surgery) to inform clinical decision-making and patient counselling
  • Understand when referral to ophthalmology is warranted, and what tertiary non-surgical tertiary treatment options might be suitable Evaluate indications, benefits, and limitations of surgical interventions for severe dry eye
  • Identify clinical indicators for IPL therapy in dry eye disease, explain its mechanism of action, and outline standard treatment protocols
  • Recognize patient selection criteria for LLLT in dry eye management, describe its mechanism, and detail recommended application protocols for optimal outcomes
  • Outline the other clinical applications for light therapy treatment
  • Critically evaluate and integrate evidence-based techniques for meibomian gland expression to optimize lipid layer restoration and tear film stability in patients with dry eye disease
  • Consider the indications, contraindications, and expected outcomes for amniotic membrane therapy for patients with advanced ocular surface disease.
  • Analyse the pathophysiological links between autoimmune disorders and Dry Eye Disease to design comprehensive management strategies that integrate systemic and ocular considerations
  • Develop multidisciplinary care plans for patients with systemic or autoimmune-related dry eye conditions. Understand the indications, benefits, and limitations of therapeutic contact lens options for complex Dry Eye cases
  • Develop communication strategies that set realistic expectations
  • Foster long-term adherence to dry eye management plans.Analyse underlying causes of initial treatment failure
  • Develop an adaptive approach that integrates: Patient education First line treatments and adjunctive treatments into a revised holistic care plan.
  • Analyze the influence of systemic factors such as sex, gender, and hormones on the development and progression of dry eye disease to support individualized patient care
  • Analyze and integrate systemic and topical medication reviews into a holistic management plan by identifying and modifying or eliminating offending agents to optimize ocular health and patient outcomes
  • Formulate a diagnostic profile for patients with discordant signs and symptoms to guide appropriate management strategies
  • Case based discussion to apply concepts learned during the didatic part of the course

Max CPD hours awarded: 16.75

Session Information

Name
Overview of Tear Film Anatomy and Physiology Definitions & Epidemiology Pathophysiology
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Clinical history-taking Symptomology Ocular Examination
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Patient Education & Communication First-Line NonPharmacological Therapies Personalised Treatment Planning
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Diet modifications
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Mechanistic pathways of anti-inflammatory treatments Evidence Behind Dry Eye Anti-Inflammatories
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
The role of antibiotics in dry eye. Mental Health
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Post-surgical dry eye disease Non-surgical tertiary treatment options Surgical
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Intense Pulsed Light Low-Level Light Therapy Other Applications of Light Therapy
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Meibomian gland expression Amniotic Membranes
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Dry eye associated with autoimmune conditions Multidisciplinary collaboration Therapeutic contact lens options
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Tests for Monitoring Treatment Success Communication Strategies for building trust and long-term compliance Troubleshooting and Revising Care Plans
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Sex, Gender, and Hormones Optimizing Holistic Care Through Medication Review Assessment of patients with only symptoms or ocular surface signs
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Webinar 1
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Webinar
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Webinar
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Assessment
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
2.5
Duration of CPD Session/Module inclusive of Assessment Component
2.5

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.